Kenneth M. Boyer, MD

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.
   Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, Sautter M, Noble AG, Withers S, Swisher C, Heydemann P, Hosten T, Babiarz J, Lee D, Meier P, McLeod R; Toxoplasmosis Study Group.
   Clin Infect Dis.
   2011 Dec
   53(11):1081-9
   
2. Identification of a sporozoite-specific antigen from Toxoplasma gondii.
   Hill D, Coss C, Dubey JP, Wroblewski K, Sautter M, Hosten T, Muñoz-Zanzi C, Mui E, Withers S, Boyer K, Hermes G, Coyne J, Jagdis F, Burnett A, McLeod P, Morton H, Robinson D, McLeod R.
   J Parasitol.
   2011 Apr
   97(2):328-37
   
3. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis
   Jamieson SE, Peixoto-Rangel AL, Hargrave AC, Roubaix LA, Mui EJ, Boulter NR, Miller EN, Fuller SJ, Wiley JS, Castellucci L, Boyer K, Peixe RG, Kirisits MJ, Elias Lde S, Coyne JJ, Correa-Oliveira R, Sautter M, Smith NC, Lees MP, Swisher CN, Heydemann P, Noble AG, Patel D, Bardo D, Burrowes D, McLone D, Roizen N, Withers S, Bahia-Oliveira LM, McLeod R, Blackwell JM
   Genes Immun
   2010 Jul
   11(5):374-83
   
4. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life
   Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Sautter M, Remington J, Meier P, McLeod R; Toxoplasmosis Study Group
   Am J Ophthalmol
   2008 Sep
   146(3):375-384
   
5. Longitudinal study of new eye lesions in treated congenital toxoplasmosis
   Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Remington J, Meier P, McLeod R; Toxoplasmosis Study Group
   Ophthalmology
   2008 Mar
   115(3):553-559. e8
   
6. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis
   Jamieson SE, de Roubaix LA, Cortina-Borja M, Tan HK, Mui EJ, Cordell HJ, Kirisits MJ, Miller EN, Peacock CS, Hargrave AC, Coyne JJ, Boyer K, Bessieres MH, Buffolano W, Ferret N, Franck J, Kieffer F, Meier P, Nowakowska DE, Paul M, Peyron F, Stray-Pedersen B, Prusa AR, Thulliez P, Wallon M, Petersen E, McLeod R, Gilbert RE, Blackwell JM
   PLoS One
   2008 Jun 4
   3(6):e2285
   
7. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy
   Benevento JD, Jager RD, Noble AG, Latkany P, Mieler WF, Sautter M, Meyers S, Mets M, Grassi MA, Rabiah P, Boyer K, Swisher C, McLeod R; Toxoplasmosis Study Group
   Arch Ophthalmol
   2008 Aug
   126(8):1152-6
   

• To watch a brief video of Kenneth M. Boyer, MD, click the play button at the lower left corner of the video frame below.
• (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
• View Transcript

• When I have a little kid who’s been sick, and I get them to smile — when they get to smiling, they’re getting better. And I’d say there’s plenty of rewards that we get in my business, but those little smiles are very important to me.

  Early on I did a fair amount of work with vaccines, and I also was involved — in the earlier part of my career when I was engaged in research — in prevention of several of the important diseases of newborn babies, specifically group B streptococcal infections. And the work that we did is probably the most important contribution to making that disease diminish dramatically in its incidence. Seeing those things is a huge satisfaction to me, and it’s an exciting thing where you can see medical progress.